Application of ET-Kyoto solution in clinical lung transplantation

Ann Thorac Surg. 2004 Jan;77(1):338-9. doi: 10.1016/s0003-4975(03)01036-1.

Abstract

We have developed a new organ preservation solution called extracellular-type trehalose-containing Kyoto (ET-Kyoto) solution. ET-Kyoto solution has been applied in clinical lung transplantation. The patient was a 49-year-old woman with diffuse panbronchiolitis. She underwent bilateral lobar lung transplantation from living donors. Each lobe was flushed with ET-Kyoto solution. After reperfusion, PaO(2) with inhalation of 100% oxygen was more than 500 Torr. Posttransplantation course was uneventful. Despite the relatively short ischemic time of this case report, ET-Kyoto solution may be feasible and safely applied in clinical lung transplantation.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Gluconates*
  • Humans
  • Hydroxyethyl Starch Derivatives*
  • Lung Transplantation*
  • Middle Aged
  • Organ Preservation Solutions*
  • Phosphates*
  • Trehalose*

Substances

  • ET-Kyoto solution
  • Gluconates
  • Hydroxyethyl Starch Derivatives
  • Organ Preservation Solutions
  • Phosphates
  • Trehalose